Pharmac agrees to fund drug for those with spinal muscular atrophy after years of lobbying
+News
Pharmac agrees to fund drug for those with spinal muscular atrophy after years of lobbying
RNZ
Wednesday 28 September 2022, 11:47 AM
Nusinersen (branded as Spinraza) would be the first medicine publicly funded for people who have spinal muscular atrophy [Image Jon Tyson via Unsplash]
New medicines for those with a rare spinal disease and people at risk of anaphylaxis are set to be publicly funded.
Pharmac is looking at funding a
Specialist GP Nikki Vadgama provides some tips to make your next paediatric eczema consult easier. She includes a review of new guidelines, resources, websites and medications for paediatric eczema management